Drug Type Small molecule drug |
Synonyms 11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine, Azatadine maleate (USP) + [2] |
Target |
Mechanism Histamine receptor antagonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (29 Mar 1977), |
Regulation- |
Molecular FormulaC24H26N2O4 |
InChIKeyKGCJWSUJYBJBBW-BTJKTKAUSA-N |
CAS Registry3978-86-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00662 | Azatadine Maleate |
Indication | Highest Phase | Country/Location | Organization |
---|---|---|---|
Rhinitis, Allergic | Withdrawn | US More | Schering AG More |